- Case report
- Open Access
- Open Peer Review
Pancytopenia and atrial fibrillation associated with chronic hepatitis C infection and presumed hepatocellular carcinoma: a case report
© Labos and Dasgupta; licensee BioMed Central Ltd. 2008
- Received: 12 February 2007
- Accepted: 11 August 2008
- Published: 11 August 2008
Pancytopenia secondary to hepatitis viral infection is a rare but noted clinical entity. An acute aplastic crisis usually occurs shortly after viral infection, however, viral serologies are usually negative and the pancytopenia is often fatal if left untreated.
A 66-year-old woman presented to the emergency department with shortness of breath and palpitations. She was found to have pulmonary edema secondary to a newly diagnosed atrial fibrillation and was treated with rate control and anticoagulation. She was found to have an anemia that was reported to be longstanding and that was apparently being investigated by a hematologist, although no diagnosis had yet been achieved. Her blood work also revealed a mild leucopenia and pronounced thrombocytopenia. The patient was admitted to ensure appropriate rate control of her atrial fibrillation and for work-up of her pancytopenia. Review of the bone marrow biopsy performed by the hematologist revealed a normal marrow with no infiltrative process. The results of the patient's blood tests ruled out a hemolytic process. There was also no evidence of infection, toxin ingestion, or recent medication that could be associated with pancytopenia. An abdominal ultrasound was ordered to rule out enlargement of the spleen and a possible consumptive coagulopathy. The spleen was mildly enlarged with a diameter of 13 cm. The liver, however, was mildly cirrhotic and a small solitary liver lesion was seen. A magnetic resonance imaging scan of the liver confirmed a single solitary solid mass and the α-fetal protein level in the serum was elevated. The patient's preliminary viral serologies were positive for hepatitis C. The patient was diagnosed with presumed hepatocellular carcinoma and referred to a hepatic surgeon for evaluation of treatment options.
Hepatitis associated aplastic anemia is an acute condition while milder more chronic presentations, such as this case, likely result from increased portal pressure generated from the resulting cirrhosis, which leads to a relative hypersplenism.
- Atrial Fibrillation
- Portal Hypertension
- Aplastic Anemia
- Bone Marrow Biopsy
A 66-year-old woman presented to the emergency department of the Montreal General Hospital with a 1-week history of dyspnea and recurrent palpitations. She had immigrated to Canada from Ethiopia 20 years previously. At the time of admission, she had been living with her daughter and was active within the household, participating in housekeeping activities. She was being treated by her family doctor for mild hypertension with an angiotensin-converting enzyme inhibitor. However, during the 24-week period prior to admission, she had been followed as an outpatient by the hematology department for moderate but unexplained normocytic anemia (110 g/l; mean corpuscular volume 89 fl), leucopenia (2.7 × 109/liter), and thrombocytopenia (68 × 109/liter). Bone marrow biopsy had not clarified the etiology of her anemia, revealing a normocellular marrow with a slight left shift in the erythroid and myeloid cell lines.
Summary of the complete blood count during admission
White blood cell
count (× 109/liter)
On peripheral smear, there were no blasts, atypical cells or schizocytes. Review of the bone marrow biopsy confirmed the previous findings and ruled out any infiltrative or dysplastic process in the bone marrow. Iron studies were not consistent with either iron-deficiency anemia or with anemia of chronic disease (iron 23 μmol/l; total iron binding capacity 68 μmol/l; ferritin 75.4 μg/l) and reticulocytes were within normal limits (76 × 109/liter). There was no evidence for hemolysis (lactic dehydrogenase 162 U/liter, billirubin total 15.2 μmol/l; billirubin direct 8 μmol/l). B12 (181 pmol/l) and folate (16.6 nmol/l) levels were within normal limits. A careful review of the patient's history did not reveal any systemic causes that might explain the pancytopenia. The patient denied any recent fever or infection. She was also persistently afebrile during the admission. There was no history of recent exposure to toxins or medications associated with marrow failure. A normal urinalysis and a negative sucrose lysis test ruled out the possibility of paroxysmal nocturnal hemoglobinuria.
There was no evidence of enlargement of the spleen or chronic stigmata of liver disease on physical examination. Chart review, however, indicated that an abdominal ultrasound performed 4 months previously had shown mild enlargement of the spleen (splenic diameter of 13 cm) but also some mild cirrhotic changes. However, liver function tests were normal, with the exception of a mildly elevated aspartate aminotransferase (AST) (alanine transaminase 33 IU/liter; AST 48 IU/liter; alkaline phosphatase 65 IU/liter; gamma-glutamyl transpeptidase 21 IU/liter), as was the coagulation profile, international normalized ratio 1.33. Nonetheless, in view of the previous ultrasound findings and the patient having immigrated from Ethiopia, viral hepatitis serologies were ordered and the ultrasound repeated.
Previously reported cases of acquired pancytopenia associated with viral hepatitis have occurred in the context of acute hepatitis rather than chronic infection, with bone marrow biopsy usually revealing a markedly hypocellular marrow [1–3]. Given the normocellular bone marrow biopsy result in our patient, it is possible that her pancytopenia resulted from a combination of the T-cell-mediated immune reaction, that is believed to occur with hepatitis virus infection [2, 3], and peripheral sequestration from hypersplenism secondary to portal hypertension induced by the cirrhosis. Although, the patient lacked any of the stigmata of portal hypertension on physical examination, the enlargement of the spleen appreciated on ultrasound is likely attributable to this fact.
The pancytopenia work-up performed in the hospital undoubtedly prolonged the duration of the patient's hospitalization. Diuresis, rate control and anticoagulation resolved the symptoms related to atrial fibrillation. However, in view of the fact that outpatient evaluation had failed to identify the etiology of her pancytopenia over a 24-week period, it was felt that a more concentrated effort on an in-patient service would be advisable. We believe that this led to a more rapid diagnosis of hepatocellular carcinoma than would have occurred in the outpatient setting, thus increasing the likelihood of a curative intervention.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Authorization to use patient data for research purposes was obtained from the Department of Professional Services at our institutions.
- Baumelou E, Guiguet M, Mary JY: Epidemiology of aplastic anemia in France: a case-control study, I: medical history and medication use. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood. 1993, 81: 1471-1478.PubMedGoogle Scholar
- Lu J, Basu A, Melenhorst JJ, Young NS, Brown KE: Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood. 2004, 103: 4588-4593. 10.1182/blood-2003-11-3959.View ArticlePubMedGoogle Scholar
- Young NS: Acquired aplastic anemia. Ann Intern Med. 2002, 136: 534-546.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.